Homepage
Energy · Oil & Gas Equipment & Services · Netherlands · Updated May 11, 12:23am
$13.13
Price
$605.2M
Market Cap
3,400
Employees
1.00
Beta
Lawrence V. Bruno
CEO
Business Description
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
Business History
Price Overview
Last updated: May 11, 2026 1:52pm (just now)$13.34
+0.21 (+1.60%)
Day Range
$13.09 – $13.36
52-Week Range
$9.72 – $20.36
50-Day MA
$16.19
200-Day MA
$15.16
Volume
173,303.00
Analyst Price Targets
Low
$17.00
Consensus
$25.00
High
$32.00
(3 analysts)
Share Structure
Outstanding
46,096,679.00
Float
45,423,209.00
Free Float
98.5%
High free float
— 98.5% of shares trade freely, ~1.5% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
APIStock Price / EPS (Diluted)
21.17
Stock Price: $13.13
EPS (Diluted): 0.68
EPS (Diluted): 0.68
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
2.66
Stock Price: $13.13
Total Equity: $279.76M
Shares: 46,500,000
Total Equity: $279.76M
Shares: 46,500,000
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
8.76
Market Cap: $605.25M
Total Debt: $152.56M
Cash: $22.85M
EBITDA: $71.12M
Total Debt: $152.56M
Cash: $22.85M
EBITDA: $71.12M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$928.9M
Market Cap: $605.25M
Total Debt: $152.56M
Cash: $22.85M
Total Debt: $152.56M
Cash: $22.85M
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
17.9%
Gross Profit: $94.28M
Revenue: $526.52M
Revenue: $526.52M
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
9.6%
Operating Income: $50.49M
Revenue: $526.52M
Revenue: $526.52M
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
5.6%
Net Income: $29.67M
Revenue: $526.52M
Revenue: $526.52M
ROE (Profit from shareholder equity)
APINet Income / Total Equity
10.7%
Net Income: $29.67M
Total Equity: $279.76M
Total Equity: $279.76M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
7.7%
Operating Income: $50.49M
Tax Rate: 33.8%
Equity: $279.76M
Total Debt: $152.56M
Cash: $22.85M
Tax Rate: 33.8%
Equity: $279.76M
Total Debt: $152.56M
Cash: $22.85M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
2.07
Current Assets: $222.37M
Current Liabilities: $107.17M
Current Liabilities: $107.17M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.55
Short-Term Debt: $0.00
Long-Term Debt: $152.56M
Total Debt: $152.56M
Total Equity: $279.76M
Long-Term Debt: $152.56M
Total Debt: $152.56M
Total Equity: $279.76M
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$11.32
Revenue: $526.52M
Shares: 46,500,000
Shares: 46,500,000
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$6.02
Total Equity: $279.76M
Shares: 46,500,000
Shares: 46,500,000
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$0.49
Operating CF: $37.18M
CapEx: -$14.59M
Shares: 46,500,000
CapEx: -$14.59M
Shares: 46,500,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.3%
Last Dividend: N/A
Stock Price: $13.13
Stock Price: $13.13
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: $29.67M
Net Income: $29.67M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares CLB against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $470.3M | $489.7M | $509.8M | $523.8M | $526.5M |
| Cost of Revenue | $386.4M | $410.8M | $415.7M | $435.5M | $432.2M |
| Gross Profit | $83.8M | $78.9M | $94.0M | $88.4M | $94.3M |
| Operating Expenses | $38.6M | $37.4M | $39.4M | $29.8M | $43.8M |
| Operating Income | $45.3M | $41.5M | $54.6M | $58.6M | $50.5M |
| Net Income | $19.7M | $19.5M | $36.7M | $31.4M | $29.7M |
| EBITDA | $63.8M | $58.7M | $70.4M | $73.3M | $71.1M |
| EPS | $0.43 | $0.42 | $0.79 | $0.67 | $0.68 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $17.7M | $15.4M | $15.1M | $19.2M | $22.8M |
| Total Current Assets | $189.1M | $211.7M | $223.1M | $226.6M | $222.4M |
| Total Assets | $580.9M | $578.4M | $586.4M | $590.4M | $597.0M |
| Current Liabilities | $90.8M | $103.1M | $88.1M | $97.6M | $107.2M |
| Long-Term Debt | $188.6M | $172.4M | $163.1M | $126.1M | $152.6M |
| Total Liabilities | $419.9M | $389.4M | $356.6M | $332.7M | $317.2M |
| Total Equity | $156.4M | $184.3M | $224.8M | $252.0M | $279.8M |
| Retained Earnings | $68.3M | $85.9M | $120.8M | $150.3M | $0 |
Cash Flow (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $36.6M | $25.0M | $24.8M | $56.4M | $37.2M |
| Capital Expenditure | -$13.5M | -$10.2M | -$10.6M | -$13.0M | -$14.6M |
| Free Cash Flow | $23.0M | $14.7M | $14.2M | $43.4M | $22.6M |
| Acquisitions (net) | $873,000 | $240,000 | $0 | $0 | -$1.2M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$8.3M | -$3.9M | -$2.2M | -$5.3M | -$12.4M |
| Net Change in Cash | $3.9M | -$2.3M | $-308,000 | $4.0M | $3.7M |
Analyst Estimates (Annual)
| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Revenue |
$520.4M $518.9M – $522.0M
|
$514.9M $513.4M – $516.4M
|
$544.4M $542.8M – $546.0M
|
$623.0M $621.2M – $624.8M
|
| EBITDA |
$75.2M $74.9M – $75.4M
|
$74.4M $74.1M – $74.6M
|
$78.6M $78.4M – $78.9M
|
$90.0M $89.7M – $90.2M
|
| Net Income |
$34.3M $34.2M – $34.5M
|
$28.7M $28.6M – $28.8M
|
$39.3M $39.1M – $39.4M
|
$68.8M $68.6M – $69.1M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +4.1% | +4.1% | +2.8% | +0.5% |
| Gross Profit Growth | -5.9% | +19.2% | -6.0% | +6.7% |
| Operating Income Growth | -8.3% | +31.6% | +7.2% | -13.8% |
| Net Income Growth | -1.4% | +88.5% | -14.4% | -5.5% |
| EBITDA Growth | -8.0% | +20.0% | +4.0% | -2.9% |
Insider Trading (Recent)
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-05-01 | Tattoli Mark Damian | M-Exempt | 250.00 | $0.00 | $0 |
| 2026-05-01 | Tattoli Mark Damian | F-InKind | 97.00 | $14.07 | $1,365 |
| 2026-05-01 | Tattoli Mark Damian | M-Exempt | 250.00 | $0.00 | $0 |
| 2026-04-01 | Murray Katherine | M-Exempt | 8,069.00 | $0.00 | $0 |
| 2026-04-01 | Murray Katherine | A-Award | 7,895.00 | $0.00 | $0 |
| 2026-04-01 | Murray Katherine | M-Exempt | 8,069.00 | $0.00 | $0 |
| 2026-04-01 | ANASTASIO CURT | M-Exempt | 8,069.00 | $0.00 | $0 |
| 2026-04-01 | ANASTASIO CURT | A-Award | 7,895.00 | $0.00 | $0 |
| 2026-04-01 | ANASTASIO CURT | M-Exempt | 8,069.00 | $0.00 | $0 |
| 2026-04-01 | Klingensmith Harvey Robert | M-Exempt | 8,069.00 | $0.00 | $0 |
| 2026-04-01 | Klingensmith Harvey Robert | A-Award | 7,895.00 | $0.00 | $0 |
| 2026-04-01 | Klingensmith Harvey Robert | M-Exempt | 8,069.00 | $0.00 | $0 |
| 2026-04-01 | Temeng Kwaku | M-Exempt | 8,069.00 | $0.00 | $0 |
| 2026-04-01 | Temeng Kwaku | A-Award | 7,895.00 | $0.00 | $0 |
| 2026-04-01 | Temeng Kwaku | M-Exempt | 8,069.00 | $0.00 | $0 |
| 2026-04-01 | MARTINOVICH ROBERT F | M-Exempt | 8,069.00 | $0.00 | $0 |
| 2026-04-01 | MARTINOVICH ROBERT F | A-Award | 7,895.00 | $0.00 | $0 |
| 2026-04-01 | MARTINOVICH ROBERT F | M-Exempt | 8,069.00 | $0.00 | $0 |
| 2026-04-01 | Carnes Martha Z. | M-Exempt | 8,069.00 | $0.00 | $0 |
| 2026-04-01 | Carnes Martha Z. | A-Award | 7,895.00 | $0.00 | $0 |
Dividend History (Last 20)
| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-05-11 | $0.01 | 2026-04-29 | 2026-05-11 | 2026-06-01 |
| 2026-02-13 | $0.01 | 2026-02-04 | 2026-02-16 | 2026-03-09 |
| 2025-11-03 | $0.01 | 2025-10-22 | 2025-11-03 | 2025-11-24 |
| 2025-08-04 | $0.01 | 2025-07-23 | 2025-08-04 | 2025-08-25 |
| 2025-05-05 | $0.01 | 2025-04-23 | 2025-05-05 | 2025-05-27 |
| 2025-02-10 | $0.01 | 2025-01-29 | 2025-02-10 | 2025-03-03 |
| 2024-11-04 | $0.01 | 2024-10-23 | 2024-11-04 | 2024-11-25 |
| 2024-08-05 | $0.01 | 2024-07-24 | 2024-08-05 | 2024-08-26 |
| 2024-05-03 | $0.01 | 2024-04-24 | 2024-05-06 | 2024-05-28 |
| 2024-02-09 | $0.01 | 2024-01-31 | 2024-02-12 | 2024-03-04 |
| 2023-11-10 | $0.01 | 2023-11-01 | 2023-11-13 | 2023-12-04 |
| 2023-08-04 | $0.01 | 2023-07-26 | 2023-08-07 | 2023-08-28 |
| 2023-05-05 | $0.01 | 2023-04-26 | 2023-05-08 | 2023-05-30 |
| 2023-02-10 | $0.01 | 2023-02-01 | 2023-02-13 | 2023-03-06 |
| 2022-11-04 | $0.01 | 2022-10-26 | 2022-11-07 | 2022-11-28 |
| 2022-08-05 | $0.01 | 2022-07-27 | 2022-08-08 | 2022-08-29 |
| 2022-05-06 | $0.01 | 2022-04-27 | 2022-05-09 | 2022-05-31 |
| 2022-02-11 | $0.01 | 2022-02-02 | 2022-02-14 | 2022-03-07 |
| 2021-11-05 | $0.01 | 2021-10-27 | 2021-11-08 | 2021-11-29 |
| 2021-08-06 | $0.01 | 2021-07-28 | 2021-08-09 | 2021-08-24 |
No community reviews yet for CLB.
Be the first — export the analysis to your AI and contribute back.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27